Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Dubinsky

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 6, 2006
New patients: should children be treated differently?M C Dubinsky
Current Opinion in Pediatrics|November 11, 1999
Novel immunosuppressive therapies for intestinal and hepatic diseasesM C Dubinsky, E G Seidman
Current Opinion in Gastroenterology|October 13, 2006
Diagnostic markers of inflammatory bowel diseaseM C Dubinsky, E G Seidman
Current Medicinal Chemistry|September 14, 2017
Therapeutic Drug Monitoring in Pediatric IBD: Current Application and Future PerspectivesS Lega, M Bramuzzo, M C Dubinsky
The American Journal of Gastroenterology|March 31, 2001
Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel diseaseM C Dubinsky, J J Ofman, M Urman, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettesE Esrailian, B M R Spiegel, L E Targownik, et al.
Gastroenterology|March 29, 2000
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel diseaseM C Dubinsky, S Lamothe, H Y Yang, et al.
Inflammatory Bowel Diseases|August 23, 2001
An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapyM C Dubinsky, P V Hassard, E G Seidman, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2013
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's diseaseT Dassopoulos, M C Dubinsky, J L Bentsen, et al.
Alimentary Pharmacology & Therapeutics|November 17, 2015
A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variablesC A Siegel, H Horton, L S Siegel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 6, 2006
New patients: should children be treated differently?M C Dubinsky
Current Opinion in Pediatrics|November 11, 1999
Novel immunosuppressive therapies for intestinal and hepatic diseasesM C Dubinsky, E G Seidman
Current Opinion in Gastroenterology|October 13, 2006
Diagnostic markers of inflammatory bowel diseaseM C Dubinsky, E G Seidman
Current Medicinal Chemistry|September 14, 2017
Therapeutic Drug Monitoring in Pediatric IBD: Current Application and Future PerspectivesS Lega, M Bramuzzo, M C Dubinsky
The American Journal of Gastroenterology|March 31, 2001
Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel diseaseM C Dubinsky, J J Ofman, M Urman, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettesE Esrailian, B M R Spiegel, L E Targownik, et al.
Gastroenterology|March 29, 2000
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel diseaseM C Dubinsky, S Lamothe, H Y Yang, et al.
Inflammatory Bowel Diseases|August 23, 2001
An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapyM C Dubinsky, P V Hassard, E G Seidman, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2013
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's diseaseT Dassopoulos, M C Dubinsky, J L Bentsen, et al.
Alimentary Pharmacology & Therapeutics|November 17, 2015
A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variablesC A Siegel, H Horton, L S Siegel, et al.
Pageof 1